In a São Paulo clinic, the administrative weight of scheduling, triaging, and following up consumes staff time, a costly inefficiency that Brazilian startup Doutor-AI believes can be automated. The company’s bet is on an operational layer powered by over 700 AI agents, designed to handle the journey from first contact to chronic care monitoring [Crunchbase, 2026]. With a $1 million pre-seed round from Airborne Ventures and a handful of early clients, the startup is aiming to prove that unifying these functions under one AI system can make care more accessible and clinics more efficient [Baguete, 2026] [Mobile Time, 2026].
The operational wedge
Doutor-AI’s platform is positioned as a comprehensive cockpit for healthcare providers. It strings together five core stages: appointment scheduling, AI triage, consultation support, post-consultation care, and longitudinal monitoring [Perplexity Sonar Pro Brief, 2024]. The company’s marketing emphasizes a plug-and-play approach to automation, suggesting clinics can deploy these agents to handle repetitive tasks [Crunchbase, 2026].
A secondary wedge is its focus on offline functionality for austere environments. The company maintains a dedicated page for military healthcare, promoting the platform as a handheld tool that can operate without a connection at the point of care [Perplexity Sonar Pro Brief, 2024].
Early traction and the path to scale
The company reports early commercial momentum, listing ten clients, including telemedicine provider Conexa, primary care network Leve Saúde, and hospital group Rede D’Or [Mobile Time, 2026]. Doutor-AI projects its systems will automate over 10 million events in its first year of operation [Mobile Time, 2026].
The $1 million pre-seed round, led by Airborne Ventures, provides the runway to pursue this early validation [Baguete, 2026].
The founder and the field
The venture is led by solo founder and CEO Maurício Honorato [RocketReach, 2024]. The competitive landscape is crowded with established players targeting similar inefficiencies.
| Competitor | Primary Focus |
|---|---|
| Nilo Saúde | Clinic management software |
| Conexa | Telemedicine & digital health |
| Laura | AI-powered clinical decision support |
Navigating a regulated reality
The company’s most credible near-term risk is the validation gap between marketing claims and clinical utility. Automating 10 million events is a volume metric; proving that automation improves patient outcomes or reduces systemic costs is a quality and efficacy challenge. The startup’s most plausible answer is to deepen its pilot partnerships with clients like Rede D’Or into published case studies.
What to watch in the next 12 months
The coming year will be defined by the transition from pilot to paid contract. Key milestones will be the conversion of one or more of its ten announced clients into a publicly referenced revenue-generating partnership, and the publication of specific efficiency gains. Financially, the current pre-seed round likely funds 18 to 24 months of operation.